Advancing Health Equity in Clinical Research
Our mission is to make progress towards racial equity in clinical research. Let’s make a difference for underrepresented patients.
At Exelixis, we recognize that many racial and ethnic communities are underrepresented in clinical research. Inclusive clinical trial design improves the quality and equity of treatments for key affected populations. Exelixis is dedicated to identifying, discussing, and implementing solutions that will increase the number of patients from underrepresented populations in all phases of clinical trials supported and sponsored by the company.
